PDX/Hu-MTM Mice for Evaluating Immune-Checkpoint Modulators for Oncology

The PDX/Hu-M™ Mice are implanted with HLA matched human patient derived xenograft (PDX) tumors for evaluating the efficacy, pharmacokinetic profile, and immune related adverse events of immune-checkpoint modulators. HuMurine’s validation matrix is specifically focused on quantifying the anti-tumor T cells response in PDX/ Hu-M™ Mice using complex flow cytometric analysis including tetramer staining.

Customizable studies available! For pricing and availability please contact us at info@humurine.com or call 909-859-1050.